Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
Allogene Therapeutics debuts CAR T Together to expand treatment access
Medical Marketing and Media
Wed, 10/12/22 - 10:57 am
Allogene Therapeutics
pharma marketing
cancer
CAR-T
Tavros signs $930M biobucks deal with Bayer's Vividion in hunt for 4 oncology targets
Fierce Biotech
Wed, 10/12/22 - 10:30 am
Vividion Therapeutics
Bayer
Tavros Therapeutics
oncology
cancer
Versant-founded biotech Nested hatches with $90M and new take on cancer drugs
MedCity News
Fri, 10/7/22 - 10:40 am
Nested Therapeutics
cancer
Versant Ventures
funding
Nested Therapeutics Raises $90M to Crack New Proteins in Precision Oncology
BioSpace
Thu, 10/6/22 - 10:53 am
Nested Therapeutics
funding
precision oncology
oncology
cancer
Keytruda taught Merck how to build a blockbuster. But manufacturing a 2nd lightning bolt is easier said than done
Fierce Pharma
Thu, 09/29/22 - 07:42 pm
Merck
Keytruda
cancer
oncology
ESMO
Real-time reviews for cell and gene therapies? Pfizer to FDA: Yes, please
Endpoints
Wed, 09/28/22 - 10:32 pm
FDA
Pfizer
cancer
RTOR
oncology
Two CRLs later, FDA endorses drug to prevent hearing loss associated with chemo
Endpoints
Wed, 09/21/22 - 10:18 am
Fennec Pharma
Pedmark
chemotherapy hearing loss
cancer
pediatric
FDA
Biden to launch new support for U.S. biotech production
CNBC
Tue, 09/13/22 - 11:00 am
Joe Biden
biotech
cancer
Roche pays $250 million to acquire Good Therapeutics and its preclinical cancer therapy
Stat
Wed, 09/7/22 - 10:45 am
Roche
M&A
Good Therapeutics
cancer
oncology
Beam details reasons for FDA hold on base editing cancer therapy
BioPharma Dive
Thu, 09/1/22 - 10:29 am
Beam Therapeutics
FDA
gene editing
cancer
Black participants severely underrepresented in global oncology studies
Clinical Trials Arena
Wed, 08/31/22 - 10:19 am
clinical trials
clinical trial diversity
oncology
cancer
Novartis bid to repurpose rare disease drug for cancer falls short in third trial
BioPharma Dive
Mon, 08/15/22 - 10:15 am
Novartis
cancer
clinical trials
lung cancer
canakinumab
Delfi aims for a cheaper liquid biopsy
EP Vantage
Fri, 08/5/22 - 10:39 am
Delfi Diagnostics
liquid biopsy
diagnostics
Medtech
cancer
solid tumors
Looking east, Sanofi pens 'pioneering' cancer drug partnership with China's Innovent
Fierce Biotech
Fri, 08/5/22 - 10:38 am
Sanofi
China
oncology
cancer
Innovent
ElevateBio, Boston Children’s launch startup to test new approach to ‘off-the-shelf’ cell therapy
BioPharma Dive
Fri, 08/5/22 - 10:36 am
ElevateBio
cell therapy
pediatric
Boston Children's Hospital
CAR-T
cancer
Racing Merck and Pfizer, Roche readies to file subcutaneous Tecentriq after posting phase 3 data
Fierce Pharma
Tue, 08/2/22 - 10:54 am
Roche
Pfizer
Merck
Tecentriq
clinical trials
cancer
checkpoint inhibitors
IDRx launches with $122M to develop combo therapy that addresses precision medicine 'whack-a-mole'
Fierce Biotech
Tue, 08/2/22 - 10:36 am
IDRx
precision medicine
cancer
JAMA study finds cancer drug data is still largely unavailable to qualified researchers
Endpoints
Mon, 08/1/22 - 10:30 am
JAMA
oncology
cancer
clinical trials
Drugmakers are slow to prove medicines that got a fast track to market really work
NPR
Sun, 07/24/22 - 07:52 pm
FDA
drug approvals
accelerated approvals
fast track
cancer
What This FDA Delay Means for Novartis
Motley Fool
Thu, 07/21/22 - 10:36 am
Novartis
FDA
cancer
tislelizumab
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »